NDC 73377-243 - Cephalexin Monohydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-243
- Package NDCs from labels
- 73377-243-01, 73377-243-02
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin Monohydrate - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-04 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-243-01 | Cephalexin Monohydrate | 10000 g in 1 DRUM | POWDER | 10000 | 2 | |
| 73377-243-02 | Cephalexin Monohydrate | 5000 g in 1 DRUM | POWDER | 5000 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 18518154-30ba-48a4-852a-3a7723030071 | 2023-12-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| cephalexin | CEPHALEXIN | Proficient Rx LP | 829244bd-93da-4a5a-a257-890cfec4c06d | 2023-12-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Major Pharmaceuticals | 1c1fbad7-bef4-42a0-a8c9-b35168f5d533 | 2023-11-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 2cb7bc3a-988b-4414-8036-fb09b2ab5767 | 2023-10-23 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | b270d537-878b-4468-b246-b704adb29ced | 2023-10-23 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 445b2a87-2e4f-483a-abe8-26fefd67514a | 2023-10-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 8073f183-e11f-41af-8bd1-1505bc7e044b | 2023-09-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| cephalexin | CEPHALEXIN | A-S Medication Solutions | 0a24b6e5-6f13-44b4-93f4-47c86945cad2 | 2023-04-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| CEPHALEXIN | CEPHALEXIN | DIRECT RX | 2d12e6a9-f7dd-25ed-e054-00144ff8d46c | 2022-09-29 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 6032b68f-16d8-41b6-bd2c-86d5406a757a | 2022-09-21 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 891b8c0e-dbf4-4b0e-ba3f-c4c49d51510d | 2022-07-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | febab51b-6b48-488a-8fd1-d24400e5df1d | 2022-07-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | dec3a1ef-1e85-4236-804b-e7a343d3a58f | 2022-05-02 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | ada7b8a5-98f4-454c-b38f-92192d4db33f | 2021-08-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Pharma-C, Inc. | bf9a6c06-11fd-4fb7-9cf5-e8e787758c1c | 2016-12-09 | Warnings, Adverse reactions | OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.